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T HERE IS considerable circumstantial evidence that hypertension is associated with abnor- 
malities of water and electrolyte metabolism. 
In man this evidence rests mainly upon the 
fact that a low sodium diet will frequently 
reduce blood pressure’s 2 and that salt-retaining 
hormones will produce hypertension.a A drug 
which lowers blood pressure by producing a 
pronounced and continued diuretic effect upon 
the kidney must, therefore, be of considerable 
interest. Before such a drug could be regarded 
as affecting the disease process, however, it 
would be necessary to show that it acts by reduc- 
ing peripheral resistance. 
At first sight, chlorothiazide did not appear 
to fit this role since its hypotensive action was 
shown by Freis4 and Dustan to result from a 
loss of plasma volume and thereby a reduction 
in cardiac output. We made measurements 
similar to these but under different circum- 
stances. Our studies consisted in measurement 
of cardiac outputs of patients who had been 
taking chlorothiazide, 1 gm. per day, con- 
tinuously for at least 1 month; whereas both 
Freis and Dustan determined their effects of 
chlorothiazide after periods of less than 2 
weeks. 
Cardiac Output: In fifteen of nineteen patients 
in our series, the cardiac output was either 
unchanged or increased after chlorothiazide 
therapy. Only four patients showed a decline 
in cardiac output. The mean control cardiac 
index for this group prior to treatment was 
3.7 L. per minute. After treatment it was 4.1 
L. per minute. Since blood pressure was re- 
duced at this time, the calculated peripheral 
resistance was also reduced by a mean of 23.6 
per cent6 (Fig. 1). 
Plasma Volume and Perifheral Resistance: Since 
cardiac output is extremely variable even with 
every effort to standardize laboratory conditions, 
we placed considerable importance upon plasma 
volume determinations made under similar 
circumstances of treatment. Here again, we 
were unable to demonstrate a physiologic dif- 
ference. In ten subjects we noted a mean 
reduction in plasma volume on only 90 m1.6 
To satisfy ourselves that these results represented 
a true difference between the acute and chronic 
stages of treatment, the effects of plasma volume 
and cardiac output of short periods of chloro- 
thiazide therapy were studied in seven patients. 
Plasma volume determinations in four patients 
showed a mean reduction of 401 ml. and cardiac 
index measurement in four ‘patients showed a 
mean reduction of 1 L. per minute. In this 
period, the fall in output was proportionately 
greater than the ‘change in blood pressure; 
consequently, total peripheral resistance in- 
creased by a mean of 14.6 per cent (Fig. 2). 
It appeared, therefore, that there was a change 
in the mechanism between the acute and chronic 
stages of treatment with chlorothiazide. The 
nature of this change is unknown but it is 
gratifying to see that the early unphysiologic 
effect of the drug is replaced after a few weeks 
of therapy by one which produces reduction of 
peripheral resistance. To suggest that this 
mechanism reverses the hypertensive process 
would be premature, but these findings suggest 
that chlorothiazide is worthy of more intensive 
study. 
Sodium Depletion and Fall in Body Water: 
While the initial attention was thrown on the 
sodium-losing ability of chlorothiazide, it has 
not been shown that sodium depletion is the 
essential requirement for the hypotensive effect. 
Hollander et al.’ demonstrated that the ex- 
changeable sodium level can be replenished by 
the administration of 9a fluorohydrocortisone 
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FIG. 1. Effect of long term therapy (more than 4 
weeks) with chlorothiazide on blood pressure, cardiac 
output and peripheral resistance. FROM: Conway, J. 
and Lauwers, P. Circulation, 21: 21, 1960.6 
without return of the blood pressure to its 
pretreatment level. Similarly, a consistent 
change in the exchangeable sodium after long 
term therapy with chlorothiazide could not 
be demonstrated in seven patients studied by 
us, there being an increase in the value in three 
patients and a small fall in four.8 Others, 
likewise, have been unable to show a fall in the 
exchangeable potassium level.g After long 
term chlorothiazide therapy the only consistent 
change that we have been able to determine is a 
fall in total body water. Since we and others10 
were unable to show a fall in extracellular fluid 
volume, we must conclude that this change in 
total body water represents a loss of intracel- 
lular water. In seven patients studied by us, 
the mean reduction was 1.9 L. This corre- 
sponded with a fall in body weight of 1.4 kg. 
It remains to be shown whether this change is 
the one responsible for the fall in blood pres- 
sure, but if chlorothiazide is affecting the hypo- 
tensive process, it would seem to us that the 
focus of attention should be on the distribution 
of body water in hypertension rather than upon 
sodium. To be sure, these two parameters 
are closely linked and, like Siamese twins, 
special tricks will have to be devised to separate 
them. 
Should loss of body water prove to be the 
essential change responsible for fall in blood 
pressure produced by chlorothiazide, the prob- 
lem will remain to elucidate the mechanism 
by which the peripheral resistance is reduced. 
The effect on the blood vessels may be upon the 
contractility of smooth muscle, upon the 
structure of whole blood vessels as suggested 
by Tobian” or possibly by an external effect 
reducing tissue pressure which is exerted on 
the vascular tree throughout its length. These 
alternatives are under active investigation at the 
present time. 
5r 
4 *a. _____------ 
,-a 
-r----S.....-. 
3 ,*~,,,,% . . . . . ..-.- “..- . 






I a I I I I I I1 I I I I I, I I I, 
0 4 8 12 16 
WEEKS OF THERAPY 
FIG. 2. Changes in cardiac output, blood pressure and body weight with initiation and maintenance 
of treatment with chlorothiazide. 
DECEMBER 1961 
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SUMMARY 
The possibility that chlorothiazide affects 
the hypertensive process is a very real one since 
the effect on the blood pressure of long term 
treatment is to reduce peripheral resistance. 
The means by which this is achieved is un- 
known. It cannot be shown to be due to loss 
of sodium since the level of exchangeable sodium 
returns to normal on long term treatment. 
The only change we have been able to observe 
is a fall in total body water which is believed 
to be due to a loss of cellular water. 
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